http://www.biohealthcapital.com Advancing Science. Accelerating Innovation. Fri, 13 Sep 2024 18:14:06 +0000 en-US hourly 1 https://wordpress.org/?v=5.7.15 http://www.biohealthcapital.com/speaker/j-r-myers/ http://www.biohealthcapital.com/?post_type=speaker&p=3530 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Wed, 03 Mar 2021 20:47:49 +0000 Mr. J.R. Myers is the Small Business Innovation Research (SBIR) Project Manager at the U.S. Army Medical Research and Development Command (USAMRDC). He is responsible for managing the Army and...]]> http://www.biohealthcapital.com/speaker/elizabeth-herman/ http://www.biohealthcapital.com/?post_type=speaker&p=2460 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Fri, 05 Apr 2019 13:43:12 +0000 Elizabeth Herman is an executive director on the federal government relations team of JPMorgan Chase & Co.   She joined JPMorgan Chase after serving for six years as legislative counsel to...]]> http://www.biohealthcapital.com/speaker/renee-hart/ http://www.biohealthcapital.com/?post_type=speaker&p=2443 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Wed, 03 Apr 2019 15:46:49 +0000 As a member of the Board of Directors and LumaCyte’s President and Chief Business Officer, Renee leads LumaCyte’s corporate development and investor relations, as well as global sales and marketing. ...]]> http://www.biohealthcapital.com/speaker/sean-j-hart/ http://www.biohealthcapital.com/?post_type=speaker&p=2441 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Wed, 03 Apr 2019 15:45:08 +0000 Dr. Hart is a highly accomplished leader, innovator and scientist who has developed transformative, cutting edge technologies throughout his career. In 2012, Dr. Hart founded LumaCyte, a revolutionary biopharmaceutical research,...]]> http://www.biohealthcapital.com/speaker/elizabeth-mccargo/ http://www.biohealthcapital.com/?post_type=speaker&p=2381 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Tue, 02 Apr 2019 13:26:36 +0000 Elizabeth McCargo is Vice Consul for the Life Sciences & Healthcare Sector at the British Embassy in Washington DC. Her role is to identify and provide advice and assistance to...]]> http://www.biohealthcapital.com/speaker/jean-charles-soria/ http://www.biohealthcapital.com/?post_type=speaker&p=2404 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Fri, 29 Mar 2019 18:33:53 +0000 Jean-Charles Soria joined Medimmune Sept 13, 2017 as Senior Vice President of R&D and Head of Oncology iMED. Dr Soria has overall responsibility for the global oncology portfolio at Medimmune...]]> http://www.biohealthcapital.com/speaker/cohava-gelber/ http://www.biohealthcapital.com/?post_type=speaker&p=2384 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Thu, 28 Mar 2019 14:50:57 +0000 Cohava Gelber, PhD, MBA, is an executive with over 25 years of experience in discovery and development of immune therapeutics and diagnostics for cancer, autoimmune disease, allergies and infectious diseases....]]> http://www.biohealthcapital.com/speaker/srujana-cherukuri/ http://www.biohealthcapital.com/?post_type=speaker&p=2382 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Thu, 28 Mar 2019 14:46:30 +0000 Before becoming CEO, Dr. Cherukuri served in multiple roles at Noble Life Sciences including Chief Operations Officer, Chief Scientific Officer, Vice President of Product Development and Operations, and Director of...]]> http://www.biohealthcapital.com/speaker/signe-pringle/ http://www.biohealthcapital.com/?post_type=speaker&p=2379 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Thu, 28 Mar 2019 14:33:03 +0000 As a Managing Director of the Office of International Investment and Trade at Maryland Department of Commerce, Ms. Pringle is responsible for the State’s international operations, including foreign direct investment...]]> http://www.biohealthcapital.com/speaker/raghav-bhargrava/ http://www.biohealthcapital.com/?post_type=speaker&p=2374 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Thu, 28 Mar 2019 13:59:31 +0000 Raghav joined NEA as an associate on the healthcare team in 2018. Prior to joining NEA, Raghav was a member of Lazard’s healthcare M&A group in New York. At Lazard,...]]> http://www.biohealthcapital.com/speaker/charles-j-andres/ http://www.biohealthcapital.com/?post_type=speaker&p=2372 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Thu, 28 Mar 2019 13:57:59 +0000 Charles Andres, Ph.D., RAC, is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati. He focuses on patent prosecution, strategic patent counseling, IP due diligence, drug...]]> http://www.biohealthcapital.com/speaker/ethel-rubin/ http://www.biohealthcapital.com/?post_type=speaker&p=2364 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Wed, 27 Mar 2019 16:56:06 +0000 Dr. Rubin works with bio and med tech companies to hit valuation inflection points, achieve strategic goals and prepare for product launch. Leading a ventures team at NIH, her focus...]]> http://www.biohealthcapital.com/speaker/norman-marcus/ http://www.biohealthcapital.com/?post_type=speaker&p=2362 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Wed, 27 Mar 2019 16:51:03 +0000 Norm Marcus is a Venture Partner with Sanderling Ventures and has more than 35 years experience in biomedical research, life science investing and the clinical practice of orthopaedic surgery, where...]]> http://www.biohealthcapital.com/speaker/brad-calvin/ http://www.biohealthcapital.com/?post_type=speaker&p=2269 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Sun, 17 Mar 2019 22:05:44 +0000 Mr. Calvin is a 25-year veteran within the diagnostics, drug development and biotechnology industries. In his role as MaxCyte’s EVP of Global Commercial Operations, he is responsible for leading the...]]> http://www.biohealthcapital.com/speaker/sara-nayeem/ http://www.biohealthcapital.com/?post_type=speaker&p=2266 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Sun, 17 Mar 2019 22:00:03 +0000 Sara joined NEA’s healthcare team in 2009 and focuses on investments in biopharmaceutical companies. She serves on the boards of Centrexion, Complexa, Cydan, Imara, and Tiburio. She previously served on...]]> http://www.biohealthcapital.com/speaker/kolaleh-eskandanian/ http://www.biohealthcapital.com/?post_type=speaker&p=2264 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Sun, 17 Mar 2019 21:31:17 +0000 Kolaleh Eskandanian, PhD, MBA, PMP is Vice President and Chief Innovation Officer at Children’s National Health System, reporting to hospital’s Executive Vice President, Physician-In-Chief and Chief Academic Officer. In this...]]> http://www.biohealthcapital.com/speaker/jose-baselga/ http://www.biohealthcapital.com/?post_type=speaker&p=2262 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Sun, 17 Mar 2019 20:51:05 +0000 José joined AstraZeneca in January 2019 as EVP, R&D Oncology and is responsible for Oncology R&D from discovery through to late-stage development. Prior to this he served as the Physician-in-Chief...]]> http://www.biohealthcapital.com/speaker/tami-howie-2/ http://www.biohealthcapital.com/?post_type=speaker&p=2260 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Sun, 17 Mar 2019 20:38:10 +0000 Tami Howie focuses her practice in the area of corporate law. She advises technology, life science and medical device companies in emerging growth and venture capital, private equity, securities offerings,...]]> http://www.biohealthcapital.com/speaker/brian-darmody/ http://www.biohealthcapital.com/?post_type=speaker&p=2257 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Sun, 17 Mar 2019 20:15:17 +0000 Brian P. Darmody, JD, Chief Executive Officer, Association of University Research Parks (AURP) Brian Darmody was announced AURP CEO in February 2019. In this new role Brian will lead AURP...]]> http://www.biohealthcapital.com/speaker/joel-s-marcus/ http://www.biohealthcapital.com/?post_type=speaker&p=2252 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Fri, 15 Mar 2019 21:05:16 +0000 Joel S. Marcus is the Chairman, Chief Executive Officer, and Founder of Alexandria Real Estate Equities, Inc. and Alexandria Venture Investments (NYSE:ARE), an urban office REIT uniquely focused on collaborative...]]> http://www.biohealthcapital.com/speaker/jack-a-khattar/ http://www.biohealthcapital.com/?post_type=speaker&p=2248 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Fri, 15 Mar 2019 20:49:01 +0000 Jack A. Khattar is the founder of Supernus Pharmaceuticals and has served as President and Chief Executive Officer and Director since 2005. From 1999 to 2005, Mr. Khattar served in...]]> http://www.biohealthcapital.com/speaker/matthias-adler/ http://www.biohealthcapital.com/?post_type=speaker&p=2222 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Wed, 13 Mar 2019 14:15:13 +0000 Matthias Adler joined Autolus as SVP, Chief Business Officer and Company Secretary in July 2017.  Previously, he served as the Executive Vice President, Business Development and Licensing, of Sucampo Pharmaceuticals...]]> http://www.biohealthcapital.com/speaker/gayatrivarma-phd/ http://www.biohealthcapital.com/?post_type=speaker&p=2215 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Mon, 11 Mar 2019 17:49:15 +0000 Gayatri Varma is Director of Partnering & Strategy at AstraZeneca where she leads business development activities focused on respiratory biologics. She engages in partnering activities including with industry, academia and...]]> http://www.biohealthcapital.com/speaker/neil-j-weissman-md/ http://www.biohealthcapital.com/?post_type=speaker&p=2213 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Mon, 11 Mar 2019 17:46:13 +0000 Neil J. Weissman, MD, FACC, FASE, is the Chief Scientific Officer for MedStar Health and President of MedStar Health Research Institute. Dr. Weissman is a professor of medicine at Georgetown...]]> http://www.biohealthcapital.com/speaker/phillip-singerman/ http://www.biohealthcapital.com/?post_type=speaker&p=2202 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Fri, 08 Mar 2019 19:45:13 +0000 Phillip Singerman is the Associate Director for Innovation and Industry Services at the National Institute of Standards and Technology (NIST). He has appointed to this position in January 2011, after...]]> http://www.biohealthcapital.com/speaker/eric-b-risser/ http://www.biohealthcapital.com/?post_type=speaker&p=2197 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Fri, 08 Mar 2019 19:35:32 +0000 Eric Risser has over 20 years of business development, strategy and portfolio management experience across both small biotechnology and large pharmaceutical companies. During his career, he has led multiple major...]]> http://www.biohealthcapital.com/speaker/lili-m-portilla-mpa/ http://www.biohealthcapital.com/?post_type=speaker&p=2195 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Fri, 08 Mar 2019 19:32:48 +0000 Lili Portilla has worked in the area of strategic alliances at the National Institutes of Health (NIH), since 1989.  She has extensive expertise in negotiating and developing commercialization strategies for...]]> http://www.biohealthcapital.com/speaker/kenneth-mills/ http://www.biohealthcapital.com/?post_type=speaker&p=2193 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Fri, 08 Mar 2019 19:22:33 +0000 Ken Mills is the founding President and Chief Executive Officer of REGENXBIO. Prior to REGENXBIO, Mr. Mills was the Chief Financial Officer and Vice President of Business Development at Meso...]]> http://www.biohealthcapital.com/speaker/dr-laurie-e-locascio/ http://www.biohealthcapital.com/?post_type=speaker&p=2191 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Fri, 08 Mar 2019 19:19:51 +0000 Locascio previously worked at the National Institute of Standards and Technology (NIST) in Gaithersburg, MD, rising from a research biomedical engineer to senior leadership positions, including, most recently, Acting Principal...]]> http://www.biohealthcapital.com/speaker/robert-g-kramer/ http://www.biohealthcapital.com/?post_type=speaker&p=2189 scott@delmarvagroup.com (admin) http://www.biohealthcapital.com/wp-content/uploads/2021/03/JRMyers-1.jpg"/> Fri, 08 Mar 2019 19:15:56 +0000 Mr. Kramer serves as the president and chief executive officer and a member of the board of directors of Emergent BioSolutions, a global life sciences company that provides specialty products...]]>